Policy Updates Medical Policy & Clinical GuidelinesMedicare AdvantageFebruary 20, 2024

Clinical Criteria updates — December 2023

Summary: On December 11, 2023, and January 5, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised. or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

See the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Share this notice with other providers in your practice and office staff.

Note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

March 22, 2024

*CC-0255

Loqtorzi (toripalimab-tpzi)

New

March 22, 2024

*CC-0256

Rivfloza (nedosiran)

New

March 22, 2024

*CC-0257

Wainua (eplontersen)

New

March 22, 2024

*CC-0185

Oxlumo (lumasiran)

Revised

March 22, 2024

*CC-0107

Bevacizumab for Non-ophthalmologic Indications

Revised

March 22, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

March 22, 2024

CC-0075

Rituximab Agents for Non-Oncologic Indications

Revised

March 22, 2024

CC-0213

Voxzogo (vosoritide)

Revised

March 22, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

March 22, 2024

*CC-0110

Perjeta (pertuzumab)

Revised

Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-051461-24-CPN50533

PUBLICATIONS: March 2024 Provider Newsletter